Other (Income)/Deductions - Net (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Jul. 02, 2017	Jul. 03, 2016	Jul. 02, 2017	Jul. 03, 2016
Other Income and Expenses [Abstract]
Royalty-related income		$ (5)	$ (5)	$ (12)	$ (12)
Certain legal and other matters, net		(4)	0	(4)
Foreign currency loss	[1]	8	8	10	17
Other, net	[2]	(3)	(5)	(8)	(4)
Other (income)/deductions—net		$ (2)	$ 4	$ (12)	$ (26)

[1] Primarily driven by costs related to hedging and exposures to certain emerging market currencies.

[2] Includes interest income and other miscellaneous income. For the six months ended July 2, 2017, also includes a settlement refund and reimbursement of legal fees related to costs incurred by Pharmaq prior to the acquisition in 2015. For the three and six months ended July 3, 2016, also includes income associated with certain state business employment tax incentive credits.